Leukocytopheresis therapy for chronic renal allograft rejection.
Tomikawa
S
S
Department of Surgery, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
Ando
Y
Y
Nomura
Y
Y
Bech
Y
Y
D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use; D015703:Antigens, CD / Q000097:blood; D001550:Benzamidines; D002908:Chronic Disease; D003404:Creatinine / Q000097:blood; D005260:Female; D006084:Graft Rejection / Q000473:pathology / Q000628:therapy*; D006146:Guanidines / Q000627:therapeutic use; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology* / Q000473:pathology / Q000502:physiology; D007937:Leukapheresis; D007962:Leukocytes / Q000276:immunology; D008297:Male; D008875:Middle Aged; D011507:Proteinuria; D012044:Regression Analysis; D013601:T-Lymphocytes / Q000276:immunology; D014184:Transplantation, Homologous
D000925:Anticoagulants; D015703:Antigens, CD; D001550:Benzamidines; D006146:Guanidines; D003404:Creatinine; C032855:nafamostat